|
시장보고서
상품코드
1877453
세계의 나노 바이오테크놀러지 시장 : 제품 유형별, 치료법별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율 및 예측(2025-2032년)Nano-biotechnology Market, By Product Type, By Therapeutics, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032 |
||||||
나노 바이오테크놀러지 시장 규모는 2024년 1,712억 3,489만 달러로 평가되었고, 2025년부터 2032년까지 연평균 9.5%의 성장률을 보일 것으로 예측됩니다.
나노바이오테크놀러지는 나노기술과 생명공학을 융합하여 의료, 농업, 환경 응용 분야를 위한 분자 및 세포 수준의 물질과 소자를 개발하는 기술입니다. 표적 약물 전달 및 진단 도구의 발전으로 연구가 가속화되고 있으며, 현재 전 세계적으로 350개 이상의 나노 의료 제품이 임상시험 단계에 있습니다. 그러나 높은 제조 비용과 규제 장벽으로 인해 대규모 상용화를 제한하고 있습니다. 정밀의료, 바이오 이미징 솔루션, 지속 가능한 농업에 대한 수요 증가는 스타트업과 기존 기업들에게 혁신의 기회를 제공합니다. 또한, MIT와 NanoTech Inc.의 제휴와 같이 대학과 생명공학 기업 간의 협력 관계는 연구개발 역량과 제품 파이프라인을 확장하고 있으며, 비용과 정책적 문제에도 불구하고 이 분야의 잠재력을 강화하고 있습니다.
나노 바이오테크놀러지 시장 역학
정밀 기술 혁신과 신흥 응용 분야가 나노바이오 시장을 주도합니다.
나노바이오테크놀러지는 나노기술과 생물학적 시스템을 융합하여 혁신적인 솔루션을 창출함으로써 의료, 농업, 환경 분야에 혁명을 불러일으키고 있습니다. 의료 분야에서는 미국 나노기술 이니셔티브가 치료 효과의 향상과 질병의 조기 발견을 가능하게 하는 표적 약물 전달 시스템 및 진단 도구 등 나노 의료의 진보를 강조하고 있습니다. 예를 들어, 미국 식품의약국(FDA)은 암 치료에 사용되는 독소루비신의 리포좀 제제인 독실(Doxorubicin) 등 여러 나노기술을 활용한 치료제를 승인한 바 있습니다. 농업 분야에서는 나노기술이 스마트 비료와 농약의 개발을 촉진하여 작물 수확량 향상과 환경 부하 감소에 기여하고 있습니다. 미국 농무부는 영양분 공급 효율과 해충 저항성을 높이는 나노 기반 농산물에 대한 연구를 지원하고 있습니다.
나노 바이오테크놀러지 시장 : 세분화 분석
세계 나노 바이오테크놀러지 시장은 제품 유형, 치료법, 응용 분야, 최종 사용자, 지역에 따라 세분화되어 있습니다.
제품 유형에 따라 시장은 나노 소재, 나노 디바이스, 나노 캐리어, 시약 및 소모품, 장비 및 도구의 5가지 카테고리로 분류됩니다. 표적 약물 전달의 중요한 역할로 인해 나노 캐리어가 시장을 주도하고 있으며, 진단 및 치료용 나노물질이 그 뒤를 잇고 있습니다. 정밀 응용을 지원하는 나노소자가 그 뒤를 잇고 있으며, 기기-도구 및 시약-소모품은 연구개발에서 중간 정도의 우선순위를 차지하고 있습니다.
시장은 치료법에 따라 암 치료, 치과 치료, 심장 치료, 정형외과 치료, 기타 치료의 5가지 카테고리로 나뉩니다. 표적 약물 전달 및 진단 기술에 대한 광범위한 조사를 통해 암 치료가 나노바이오기술 분야를 주도하고, 그 다음으로 심혈관 질환을 대상으로 하는 심장 치료가 그 뒤를 잇고 있습니다. 정형외과와 치과 치료는 중간 정도의 관심을 받고 있으며, 신경질환과 감염질환을 포함한 다른 치료 영역은 신흥이지만 우선순위가 낮습니다.
나노바이오 시장 - 지역별 분석
나노 바이오테크놀러지 분야는 전략적 제휴와 인수를 원동력으로 삼아 전 세계적으로 괄목할만한 성장을 이루고 있습니다. 2025년, 알바니 대학 나노소재 및 나노일렉트로닉스 첨단기술센터(CATN2)는 반도체, 마이크로시스템, 바이오메디컬 기술 연구 추진을 위해 1,000만 달러의 주정부 보조금을 획득했습니다. 이 자금은 세계 파운드리, IBM을 포함한 150개 이상의 기업과의 제휴를 지원하여 약 16억 달러의 경제적 효과와 1,750명 이상의 고용 창출에 기여하고 있습니다. 또한, 캐나다의 지질 나노입자 기술 전문 기업인 정밀 나노시스템즈(Precision Nanosystems)가 사이토바에 인수되어 mRNA 백신 개발 역량이 강화되었습니다. 이러한 움직임은 산학협력과 전략적 기업 통합을 통해 추진되는 이 분야의 역동적인 성장을 뒷받침하고 있습니다.
나노바이오 시장 - 국가별 분석
미국은 전략적 합병과 제휴를 통해 나노바이오테크놀러지 분야에서 세계적인 리더의 지위를 유지하고 있습니다. 2025년 3월 아스트라제네카는 벨기에 바이오텍 기업 에소바이오텍을 최대 10억 달러에 인수하며, 특히 암과 자가면역질환에 대한 세포치료 역량을 강화하기 위해 노력하고 있습니다. 이번 인수는 최대 12억 달러 규모의 그라셀 바이오테크놀러지스(Gracell Biotechnologies) 인수, 세포치료제 개발을 위한 메릴랜드 주에 3억 달러 투자 등 다른 주요 투자에 이은 후속 조치다. 또한, 미국 국가 나노기술 이니셔티브는 학계와 산업계가 협력하는 다학제적 연구에 지속적으로 자금을 지원하여 나노 의료 및 진단 기술의 혁신을 촉진하고 있습니다. 이러한 발전은 학계와 산업계의 협력과 전략적 기업 통합에 의해 추진되는 이 분야의 역동적인 성장을 강조하고 있습니다.
나노바이오 시장 : 경쟁 구도
나노 바이오테크놀러지의 경쟁 환경은 혁신과 시장 지위 강화를 위한 전략적 합병, 인수, 제휴로 특징지어집니다. 2025년 아스트라제네카는 세포치료 기술, 특히 암 및 자가면역질환 분야를 강화하기 위해 에소바이오텍을 최대 10억 달러에 인수했습니다. 마찬가지로 사노피는 호흡기 백신 제품 확장을 위해 영국 바이오기업 바이스바이오를 11억 5,000만 달러에 인수할 계획을 발표했습니다. 미국에서는 알바니 대학 나노재료 및 나노일렉트로닉스 첨단기술센터(CATN2)가 반도체 및 마이크로전자 연구에서의 역할을 강화하기 위해 1,000만 달러의 주정부 보조금을 획득했습니다. 이를 통해 세계 파운드리, IBM과 같은 기업과의 민관협력을 촉진하고 있습니다. 이러한 움직임은 전략적 기업 행동과 기관 지원에 의해 추진되는 나노바이오기술 분야의 역동적인 특성을 잘 보여주고 있습니다.
목차
제1장 나노 바이오테크놀러지 시장 개요
- 분석 범위
- 시장 추정 기간
제2장 주요 요약
- 시장 내역
- 경쟁 인사이트
제3장 나노 바이오테크놀러지 주요 시장 동향
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 시장 향후 동향
제4장 나노 바이오테크놀러지 시장 : 산업 분석
- PEST 분석
- Porter의 Five Forces 분석
- 시장 성장 전망 : 맵핑
- 규제 체제 분석
제5장 나노 바이오테크놀러지 시장 : 높아지는 지정학적 긴장의 영향
- COVID-19 팬데믹의 영향
- 러시아·우크라이나 전쟁의 영향
- 중동 분쟁의 영향
제6장 나노 바이오테크놀러지 시장 구도
- 나노 바이오테크놀러지 시장 점유율 분석(2024년)
- 주요 제조업체별 분석 데이터
- 기존 기업 분석
- 신규 기업 분석
제7장 나노 바이오테크놀러지 시장 : 제품 유형별
- 개요
- 부문별 점유율 분석 : 제품 유형별
- 나노재료
- 나노튜브
- 나노입자
- 나노 디바이스
- 나노 칩
- 바이오센서
- 나노 캐리어
- 리포솜
- 덴드리머
- 시약 및 소모품
- 기구·툴
제8장 나노 바이오테크놀러지 시장 : 치료법별
- 개요
- 부문별 점유율 분석 : 치료법별
- 암치료
- 치과 치료
- 심장 치료
- 정형외과 치료
- 기타
제9장 나노 바이오테크놀러지 시장 : 용도별
- 개요
- 부문별 점유율 분석 : 용도별
- 약물전달
- 진단 및 영상 진단
- 재생의료
- 조직공학
- 백신 개발
제10장 나노 바이오테크놀러지 시장 : 최종사용자별
- 개요
- 부문별 점유율 분석 : 최종사용자별
- 제약 기업 및 바이오테크놀러지 기업
- 연구기관
- 병원 및 진단실험실
- 학술기관
- 기타
제11장 나노 바이오테크놀러지 시장 : 지역별
- 서론
- 북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
- 유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
- 아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
- 라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
- 중동 및 아프리카(MEA)
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타
제12장 주요 벤더 분석 : 나노 바이오테크놀러지 업계
- 경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 포지셔닝
- 기업 개요
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Carl Zeiss AG
- Danaher Corporation
- GE Healthcare
- Hitachi High-Technologies Corporation
- Illumina, Inc.
- JEOL Ltd.
- Merck KGaA
- Nanobiotix
- Nikon Corporation
- Oxford Instruments plc
- PerkinElmer, Inc.
- Qiagen NV
- Shimadzu Corporation
- Tecan Group Ltd.
- Thermo Fisher Scientific, Inc.
- Others
제13장 AnalystView의 전방위적 분석
LSHNano-biotechnology Market size was valued at US$ 171,234.89 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.
Nano-biotechnology integrates nanotechnology with biotechnology to develop materials and devices at a molecular and cellular level for healthcare, agriculture, and environmental applications. Advancements in targeted drug delivery and diagnostic tools have accelerated research, with over 350 nanomedicine products currently in clinical trials globally. However, high manufacturing costs and regulatory hurdles limit large-scale commercialization. Growing demand for precision medicine, bio-imaging solutions, and sustainable agricultural practices presents opportunities for startups and established companies to innovate. Additionally, collaborations between universities and biotech firms, such as MIT partnering with NanoTech Inc., are expanding R&D capabilities and product pipelines, reinforcing the sector's potential despite cost and policy challenges.
Nano-biotechnology Market- Market Dynamics
Precision Innovations and Emerging Applications Propel Nano-biotechnology Market
Nano-biotechnology is revolutionizing healthcare, agriculture, and environmental sectors by merging nanotechnology with biological systems to create innovative solutions. In the medical field, the U.S. National Nanotechnology Initiative highlights advancements in nanomedicine, including targeted drug delivery systems and diagnostic tools that enhance treatment efficacy and early disease detection. For instance, the FDA has approved several nano-enabled therapeutics, such as Doxil, a liposomal formulation of doxorubicin used in cancer therapy. In agriculture, nanotechnology facilitates the development of smart fertilizers and pesticides, improving crop yield and reducing environmental impact. The U.S. Department of Agriculture has supported research into nano-based agricultural products that enhance nutrient delivery and pest resistance.
Nano-biotechnology Market- Segmentation Analysis:
The Global Nano-biotechnology Market is segmented on the basis of Product Type, Therapeutics, Application, End-User, and Region.
The market is divided into five categories based on product type: Nanomaterials, Nanodevices, Nanocarriers, Reagents & Consumables, and Instruments & Tools. Nanocarriers lead the market due to their critical role in targeted drug delivery, followed by nanomaterials for diagnostics and therapeutics. Nanodevices rank next, supporting precision applications, while instruments & tools and reagents & consumables hold moderate priority in research and development.
The market is divided into five categories based on Therapeutics: Cancer, Dental, Cardiac, Orthopedic, and Others. Cancer therapeutics dominate the nano-biotechnology segment owing to extensive research in targeted drug delivery and diagnostics, followed by cardiac applications addressing cardiovascular disorders. Orthopedic and dental applications hold a moderate focus, while other therapeutic areas, including neurological and infectious diseases, have emerging but lower priority.
Nano-biotechnology Market- Geographical Insights
The nano-biotechnology sector is experiencing significant global expansion, fueled by strategic collaborations and acquisitions. In 2025, the University at Albany's Center for Advanced Technology in Nanomaterials and Nanoelectronics (CATN2) secured a $10 million state grant to advance research in semiconductors, microsystems, and biomedical technologies. This funding supports partnerships with over 150 companies, including GlobalFoundries and IBM, contributing to an estimated economic impact of $1.6 billion and the creation of more than 1,750 jobs. Additionally, Precision NanoSystems, a Canadian firm specializing in lipid nanoparticle technologies, was acquired by Cytiva, enhancing capabilities in mRNA vaccine development. These developments underscore the sector's dynamic growth, driven by academic-industry partnerships and strategic corporate consolidations.
Nano-biotechnology Market- Country Insights
The United States remains a global leader in nano-biotechnology, marked by strategic mergers and collaborations. In March 2025, AstraZeneca acquired Belgian biotech firm EsoBiotec for up to $1 billion, aiming to enhance its cell therapy capabilities, particularly in cancer and autoimmune diseases. This acquisition follows other significant investments, including the purchase of Gracell Biotechnologies for up to $1.2 billion and a $300 million investment in Maryland for cell therapy development. Additionally, the U.S. National Nanotechnology Initiative continues to fund interdisciplinary research, fostering innovation in nanomedicine and diagnostics. These developments underscore the sector's dynamic growth, driven by academic-industry partnerships and strategic corporate consolidations.
Nano-biotechnology Market- Competitive Landscape:
The competitive landscape of nano-biotechnology is marked by strategic mergers, acquisitions, and collaborations that enhance innovation and market positioning. In 2025, AstraZeneca acquired EsoBiotec for up to $1 billion to advance its cell therapy capabilities, particularly in cancer and autoimmune diseases. Similarly, Sanofi announced plans to acquire UK-based biotech firm Vicebio for $1.15 billion, aiming to enhance its respiratory vaccine offerings. In the U.S., the University at Albany's Center for Advanced Technology in Nanomaterials and Nanoelectronics (CATN2) secured a $10 million state grant to bolster its role in semiconductor and microelectronics research, fostering public-private partnerships with companies like GlobalFoundries and IBM. These developments underscore the dynamic nature of the nano-biotechnology sector, driven by strategic corporate actions and institutional support.
Recent Developments:
In September 2024, scientists at the National Institute of Agricultural Botany (NIAB) developed a diagnostic kit to detect antibiotics in animal food, alongside a nano-mineral biocapsule for targeted delivery of nutrients, drugs, and bioactive molecules, enhancing food safety and precision nutrition.
In September 2024, NanoSyrinx secured £10 million (USD 12.2 million) funding to develop its innovative nano syringe delivery platform, enabling precise transport of peptide and protein payloads directly into the cytosol of targeted cells for advanced therapeutic applications.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NANO-BIOTECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Carl Zeiss AG
- Danaher Corporation
- GE Healthcare
- Hitachi High-Technologies Corporation
- Illumina, Inc.
- JEOL Ltd.
- Merck KGaA
- Nanobiotix
- Nikon Corporation
- Oxford Instruments plc
- PerkinElmer, Inc.
- Qiagen N.V.
- Shimadzu Corporation
- Tecan Group Ltd.
- Thermo Fisher Scientific, Inc.
- Others
GLOBAL NANO-BIOTECHNOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Nanomaterials
- Nanotubes
- Nanoparticles
- Nanodevices
- Nanochips
- Biosensors
- Nanocarriers
- Liposomes
- Dendrimers
- Reagents & Consumables
- Instruments & Tools
GLOBAL NANO-BIOTECHNOLOGY MARKET, BY THERAPEUTICS- MARKET ANALYSIS, 2019 - 2032
- Cancer
- Dental
- Cardiac
- Orthopedic
- Others
GLOBAL NANO-BIOTECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Drug Delivery
- Diagnostics & Imaging
- Regenerative Medicine
- Tissue Engineering
- Vaccine Development
GLOBAL NANO-BIOTECHNOLOGY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Hospitals & Diagnostic Labs
- Academic Institutions
- Others
GLOBAL NANO-BIOTECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Nano-biotechnology Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Nano-biotechnology Market Snippet by Product Type
- 2.1.2. Nano-biotechnology Market Snippet by Therapeutics
- 2.1.3. Nano-biotechnology Market Snippet by Application
- 2.1.4. Nano-biotechnology Market Snippet by End-User
- 2.1.5. Nano-biotechnology Market Snippet by Country
- 2.1.6. Nano-biotechnology Market Snippet by Region
- 2.2. Competitive Insights
3. Nano-biotechnology Key Market Trends
- 3.1. Nano-biotechnology Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Nano-biotechnology Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Nano-biotechnology Market Opportunities
- 3.4. Nano-biotechnology Market Future Trends
4. Nano-biotechnology Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Nano-biotechnology Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Nano-biotechnology Market Landscape
- 6.1. Nano-biotechnology Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Nano-biotechnology Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Nanomaterials
- 7.1.2.1. Nanotubes
- 7.1.2.2. Nanoparticles
- 7.1.3. Nanodevices
- 7.1.3.1. Nanochips
- 7.1.3.2. Biosensors
- 7.1.4. Nanocarriers
- 7.1.4.1. Liposomes
- 7.1.4.2. Dendrimers
- 7.1.5. Reagents & Consumables
- 7.1.6. Instruments & Tools
8. Nano-biotechnology Market - By Therapeutics
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Therapeutics, 2024 & 2032 (%)
- 8.1.2. Cancer
- 8.1.3. Dental
- 8.1.4. Cardiac
- 8.1.5. Orthopedic
- 8.1.6. Others
9. Nano-biotechnology Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 9.1.2. Drug Delivery
- 9.1.3. Diagnostics & Imaging
- 9.1.4. Regenerative Medicine
- 9.1.5. Tissue Engineering
- 9.1.6. Vaccine Development
10. Nano-biotechnology Market - By End-User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
- 10.1.2. Pharmaceutical & Biotechnology Companies
- 10.1.3. Research Institutes
- 10.1.4. Hospitals & Diagnostic Labs
- 10.1.5. Academic Institutions
- 10.1.6. Others
11. Nano-biotechnology Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Nano-biotechnology Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Nano-biotechnology Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Nano-biotechnology Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Nano-biotechnology Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Nano-biotechnology Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Nano-biotechnology Industry
- 12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. Affymetrix, Inc.
- 12.2.2. Agilent Technologies, Inc.
- 12.2.3. Becton, Dickinson and Company
- 12.2.4. Bio-Rad Laboratories, Inc.
- 12.2.5. Bruker Corporation
- 12.2.6. Carl Zeiss AG
- 12.2.7. Danaher Corporation
- 12.2.8. GE Healthcare
- 12.2.9. Hitachi High-Technologies Corporation
- 12.2.10. Illumina, Inc.
- 12.2.11. JEOL Ltd.
- 12.2.12. Merck KGaA
- 12.2.13. Nanobiotix
- 12.2.14. Nikon Corporation
- 12.2.15. Oxford Instruments plc
- 12.2.16. PerkinElmer, Inc.
- 12.2.17. Qiagen N.V.
- 12.2.18. Shimadzu Corporation
- 12.2.19. Tecan Group Ltd.
- 12.2.20. Thermo Fisher Scientific, Inc.
- 12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
